Rally Blog, Rally Researchers, Research
What are Oncolytic Viruses? A key part of Rally’s mission is to find better treatments with fewer long-term side effects, and for almost a decade. Rally has invested for almost a decade in oncolytic virus treatments. A promising, cutting-edge, targeted immunotherapy....
Childhood Cancer, Rally Blog, Rally Researchers, Success Stories
New and Innovative Study Technique for Osteosarcoma Metastasis Osteosarcoma (OS) is a type of cancer that begins in the cells that form bones, and mainly affects teenagers and young adults. In metastatic osteosarcoma, the cancer spreads from the primary bone site to...
Rally Blog, Rally Researchers, Research, Success Stories
New RNA Therapies for Glioblastoma from Small Phase 1 Study Glioblastoma (GBM) in children and adults is a deadly brain tumor with a poor prognosis. Current treatment includes surgery to remove as much of the tumor as possible, followed by radiation and chemotherapy....
Rally Blog, Research, Success Stories
AML Treatment Developments Rally Foundation for Childhood Cancer Research is excited to announce new developments in the treatment of childhood acute myeloid leukemia (AML) emerging from research in the Meshinchi laboratory at the Fred Hutchinson Cancer Research...
Rally Blog, Rally Researchers, Research, Success Stories
The New England Journal of Medicine Chills ran up and down my arms when I opened the link that Rally-funded researcher Dr. Gregory Friedman sent. I was staring at the New England Journal of Medicine logo, an article about Dr. Friedman’s brain cancer research and an...
